Ke YN - Search Results

1

Long-term efficacy of olmesartan medoxomil in Chinese hypertensive patients as assessed by clinic, ambulatory and home blood pressure measurements.

Wang JG, Sun NL, Ke YN, Zhang BH, Ikegami N, Zhu JR. Wang JG, et al. Among authors: ke yn. Clin Drug Investig. 2012 Nov;32(11):729-34. doi: 10.1007/s40261-012-0003-7. Clin Drug Investig. 2012. PMID: 23018282 Free PMC article. Clinical Trial.

2

Ambulatory arterial stiffness index correlates with ambulatory pulse pressure but not dipping status in patients with grade 1/grade 2 essential hypertension.

Qin T, Jiang H, Jiao Y, Ke Y, Sun N, Wang J, Zhu J. Qin T, et al. J Int Med Res. 2014 Dec;42(6):1323-34. doi: 10.1177/0300060514548288. Epub 2014 Oct 20. J Int Med Res. 2014. PMID: 25332228 Free article.

3

Using different methods to evaluate the efficacy of olmesartan medoxomil in Chinese patients with mild to moderate essential hypertension according to ambulatory blood pressure monitoring.

Jiang H, Ke YN, Sun NL, Wang JG, Hou MW, Zhu JR; Olmesartan Medoxomil Clinical Collaborative Panel of EXPO Study. Jiang H, et al. Among authors: ke yn. Blood Press Monit. 2012 Oct;17(5):193-7. doi: 10.1097/MBP.0b013e3283588513. Blood Press Monit. 2012. PMID: 22922298

4

Reduction of the morning blood pressure surge treated with olmesartan in Chinese patients with mild to moderate essential hypertension--a multicenter, open-label, single treatment group clinical study.

Jiao Y, Ke Y, Sun N, Wang J, Deng W, Zhu J; Olmesartan Medoxomil Clinical Collaborative Panel; EXPO Study. Jiao Y, et al. Eur Rev Med Pharmacol Sci. 2012 May;16(5):653-9. Eur Rev Med Pharmacol Sci. 2012. PMID: 22774407 Clinical Trial.

5

[Efficacy and safety of olmesartan medoxomil versus losartan potassium in Chinese patients with mild to moderate essential hypertension].

Zhu JR, Cai NS, Fan WH, Zhu DL, He B, Wu ZG, Ke YN, Guo JX, Ma H, Huang J, Li XL, Chen YZ. Zhu JR, et al. Among authors: ke yn. Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Oct;34(10):877-81. Zhonghua Xin Xue Guan Bing Za Zhi. 2006. PMID: 17217710 Clinical Trial. Chinese.

6

[Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy].

Ke YN, Huang J, Zhu JR; Valsartan/Amlodipine Single Pill Combination Study Group. Ke YN, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Sep;37(9):794-9. Zhonghua Xin Xue Guan Bing Za Zhi. 2009. PMID: 20128376 Clinical Trial. Chinese.

7

Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy.

Ke Y, Zhu D, Hong H, Zhu J, Wang R, Cardenas P, Zhang Y. Ke Y, et al. Curr Med Res Opin. 2010 Jul;26(7):1705-13. doi: 10.1185/03007995.2010.487391. Curr Med Res Opin. 2010. PMID: 20469975 Clinical Trial.

8

Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial.

Watanabe LA, Wei M, Sun N, Kim D, Chiang CE, Ke Y, Tseng CD, Coloma R, Vala M, Massaad R, Feig P, Guptha S. Watanabe LA, et al. Curr Med Res Opin. 2006 Oct;22(10):1955-64. doi: 10.1185/030079906X132514. Curr Med Res Opin. 2006. PMID: 17022855 Clinical Trial.

9

[A randomized, double-blind, double-dummy study comparing a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg to telmisartan 80 mg in Chinese hypertensive patients who failed to respond adequately to telmisartan 80 mg].

Chen SX, Zhang J, Chen SL, Chen JZ, Yan XW, Ke YN, DU FH, Zhang CZ, Qin YW, Pu K, Zhu DL. Chen SX, et al. Among authors: ke yn. Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Apr;36(4):300-4. Zhonghua Xin Xue Guan Bing Za Zhi. 2008. PMID: 19100003 Clinical Trial. Chinese.

10

[The effects of olmesartan on ambulatory blood pressures and blood pressure variability in patients with mild to moderate essential hypertension].

Li J, Qin T, Jiang H, Wang H, Ke Y. Li J, et al. Zhonghua Nei Ke Za Zhi. 2014 Oct;53(10):788-92. Zhonghua Nei Ke Za Zhi. 2014. PMID: 25567150 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page